| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |